Fish, marine n-3 polyunsaturated fatty acids and coronary heart disease: A minireview with focus on clinical trial data

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 75, Issue 3, 2006, Pages 191-195

  Schmidt, Erik Berg ^a   Rasmussen, Lars Hvilsted ^a   Rasmussen, Jeppe Grøndahl ^a   Joensen, Albert Marni ^a   Madsen, Martin Bruun ^a   Christensen, Jeppe Hagstrup ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; FISH OIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PRAVASTATIN; SIMVASTATIN;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONTAMINATION; CORONARY ARTERY BYPASS SURGERY; DEFIBRILLATOR; DOSE RESPONSE; FISH; FOLLOW UP; FOOD INTAKE; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; RISK REDUCTION; SAFETY; SURVIVAL; THROMBOSIS;

ANIMALS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; CORONARY DISEASE; FATTY ACIDS, OMEGA-3; FISH OILS; FISHES; HUMANS; RISK FACTORS;

EID: 33747871723     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2006.05.008     Document Type: Article

References (34)

1. Schmidt E.B. n-3 fatty acids and the risk of coronary heart disease (thesis). Dan. Med. Bull. 44 (1997) 1-22
2. Schmidt E.B., Arnesen H., De Caterina R., Rasmussen H., and Kristensen S.D. Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part I: background, epidemiology, animal data, effects on risk factors and safety. Thromb. Res. 115 (2005) 163-170
3. Kris-Etherton P.M., Harris W.S., and Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
4. He K., Song Y., Daviglus M.L., et al. Accumulated evidence on fish consumption and coronary heart disease mortality. A meta-analysis of cohort studies. Circulation 109 (2004) 2705-2711
5. Iso H., Kobayashi M., Ishihara J., et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113 (2006) 195-202
6. Thies F., Garry J.G., Yaqoob P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised trial. Lancet 361 (2003) 477-485
7. Sacks F.M., Stone P.H., Gibson M., Silverman D.I., Rosner B., and Pasternak R.C. Controlled trial of fish oil for regression of human coronary atherosclerosis. J. Am. Coll. Cardiol. 25 (1995) 1492-1498
8. von Schacky C., Angerer P., Kothny W., Theisen K., and Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 130 (1999) 554-562
9. Zampolli A., Bysted A., Leth T., Mortensen A., De Caterina R., and Falk E. Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Artherosclerosis 184 (2005) 78-85
10. Schmidt E.B., Arnesen H., Christensen J.H., Rasmussen L.H., Kristensen S.D., and DeCaterina R. Marine n-3 polyunsaturated fatty acids and coronary heart disease. Part II: clinical trials and recommendations. Thromb. Res. 115 (2005) 257-262
11. McLennan P.L. Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 36 Suppl. (2001) S111-S114
12. Leaf A., Xiao Y.F., Kang J.X., and Billmann G.E. Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias. J. Membr. Biol. 206 (2005) 129-139
13. Schmidt E.B. Marine n-3 fatty acids and thrombosis. Thromb. Res. 111 (2003) 9-10
14. Seierstad S.L., Seljeflot I., Johansen O., et al. Dietary intake of differently fed salmon; the influence on markers of human artheroschlerosis. Eur. J. Clin. Invest. 35 (2005) 52-59
15. Madsen T., Christensen J.H., Blom M., and Schmidt E.B. The effect of n-3 fatty acids on CRP levels in healthy subjects. Br. J. Nutr. 89 (2003) 517-522
16. Geelen A., Brouwer I.A., Schouten E.G., Kluft C., Katan M.B., and Zock P.L. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur. J. Clin. Nutr. 58 (2004) 1440-1442
17. Rissanen T., Voutilainen S., Nyyssonen K., and Lakka T.A. Fish-oil derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events. The Kuopio ischaemic heart disease risk factor study. Circulation 102 (2000) 2677-2679
18. Yokoyama M. Effects of eicosapentaenoic acid (EPA) on major cardiovascular events in hypercholesterolemic patients: The Japan EPA Lipid Intervention Study (JELIS). Circulation 112 (2005) 3362-3363
19. Landmark K., Abdelnoor M., Urdal P., et al. Use of fish oils appears to reduce infarct size as estimated from peak creatine kinase and lactate dehydrogenase activities. Cardiology 89 (1998) 94-102
20. Burr M.L., Ashfield-Watt P.A.L., Dunstan F.D.J., et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur. J. Clin. Nutr. 57 (2003) 193-200
21. Burr M.L., Fehily A.M., Gilbert J.F., et al. Effects of changes in fat, fish, and fibre intakes on death and reinfarction: diet and reinfarction trial (DART). Lancet 2 (1989) 757-761
22. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
23. Nilsen D.W., Albrektsen G., Landmark K., Moen S., Aarsland T., and Woie L. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am. J. Clin. Nutr. 74 (2001) 50-56
24. Arnesen H. n-3 fatty acids and revascularization procedures. Lipids 36 Suppl. (2001) S103-S106
25. Eritsland J., Arnesen H., Grønseth K., Fjeld N.B., and Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am. J. Cardiol. 77 (1996) 31-36
26. Christensen J.H. n-3 fatty acids and the risk of sudden cardiac death with emphasis on heart rate variability (thesis). Dan. Med. Bull. 50 (2003) 347-367
27. Mozaffarian D., Geelen A., Brouwer I., Geleijnse J., Zock P.L., and Katan M. Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation 112 (2005) 1945-1952
28. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Circulation 105 (2002) 1897-1903
29. Leaf A., Albert C.M., Josephson M., et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 112 (2005) 2762-2768
30. Raitt M.H., Connor W.E., and Morris C. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators. A randomized controlled trial. J. Am. Med. Assoc. 293 (2005) 2884-2891
31. Christensen J.H., Riahi S., Schmidt E.B., et al. n-3 fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators. Europace 7 (2005) 338-344
32. Schrepf R., Limmert T., Weber P.C., Theisen K., and Sellmeyer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 363 (2004) 1441-1442
33. L. Hooper, R.L. Thompson, R.A. Harrison, et al., Omega 3 fatty acids for prevention and treatment of cardiovascular disease, The Cochrane Database of Systemic Reviews (2004) 3. Art. No. CD003177.pub2, doi:10.1002/14651858. CD003177.pub2.
34. Hooper L., Thompson R.L., Harrison R.A., et al. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. Br. Med. J. 332 (2006) 739-740